News Sentiment

PEN sentiment intelligence

Penumbra Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 61 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 318.10 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

75/100 classification confidence.

Company focus 51

directly relevant articles

Source quality 5

high-authority source matches

Trend context Trend inactive

-0.1% over one week, -0.2% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Analyst Report: Penumbra, Inc.

Market Reaction

Balanced read

52/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 75/100 classification
One-week reaction -0.1% Price digesting
Trend fit Trend inactive -0.2% over four weeks
Fair value 23.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 49
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 51
Industry context 10
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
TradingView 9
simplywall.st 4
Stock Titan 4
Morningstar 3
Stock Traders Daily 2
MedTech Dive 2
Investing.com 2

Event Lens

What the news is about

Classified themes
Market update 25
Earnings 21
Deals and strategy 7
Analyst action 3
Regulatory and legal 3
Guidance 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 61
TradingView Direct company coverage

Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain?

Penumbra recently received CE Mark approval in Europe for its THUNDERBOLT technology, a computer-assisted vacuum thrombectomy (CAVT) device for acute ischemic stroke, following FDA approval in the U.S. This expansion is expected to boost Penumbra's international revenues, which a

Tone
Positive 66/100
Event
Regulatory and legal
Published
18 Jun 2026 17:09
Source
TradingView
MedTech Dive Direct company coverage

Penumbra wins CE mark for Thunderbolt clot removal tech

Penumbra has secured a CE mark for its Thunderbolt computer-assisted vacuum thrombectomy device, allowing its launch in Europe for stroke patients. This European certification follows FDA clearance and positions Penumbra for global expansion, which could be significantly bolstere

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 15:09
Source
MedTech Dive
TradingKey Direct company coverage

Penumbra Inc (PEN) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Penumbra Inc (PEN), noting its current valuation score of 7.10, which ranks 176 out of 204 in its industry. The company's current P/E ratio is 72.21, significantly below its recent high but above its recent low. The article indicates

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 05:17
Source
TradingKey
TradingView Direct company coverage

Penumbra Inc SEC 10-K Report

Tone
Neutral 50/100
Event
Market update
Published
25 Feb 2026 08:00
Source
TradingView